A small molecule inhibitor, SLC-391 has potent efficacy against many cancer cell lines, by inhibiting AXL/PI3K/AKT-dependent cell proliferation and survival (50 mg/kg p.o, CT-26 murine colon carcinoma cell line). This evidence concerns the gene AXL and cancer.